Cardinal Health Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Cardinal Health Bundle
Unlock Cardinal Health’s strategic blueprint with our concise Business Model Canvas—revealing key value propositions, partnerships, and revenue drivers that power its market leadership. Ideal for investors, consultants, and founders seeking actionable, sector-specific insights. Purchase the full, editable Canvas to benchmark strategy and accelerate decision-making.
Partnerships
Strategic sourcing agreements with pharmaceutical manufacturers secure branded, generic and specialty drugs at scale, leveraging an industry structure where the three major distributors account for over 80% of U.S. drug distribution. Co-planning on demand forecasts with manufacturers reduces stockouts and obsolescence. Compliance collaboration enforces DSCSA November 27, 2023 serialization and GMP traceability across the chain. Joint programs support product launches and market access as specialty drugs now represent ~50% of U.S. drug spend.
OEM partners supply devices, disposables, diagnostics and lab supplies that underpin Cardinal Health’s channel breadth; Cardinal Health reported net sales of $181.2 billion in fiscal 2024, reflecting scale advantages with supplier networks. Vendor-managed inventory and consolidated purchasing drive lower total landed cost—clients typically see double-digit inventory reductions—while QC and regulatory alignment preserve product integrity and patient safety. Co-development with suppliers enables private-label and exclusive SKUs, supporting differentiated margins and faster time-to-market.
Cardinal Health partners with group purchasing organizations that align contracting to deliver aggregated pricing for providers, leveraging GPOs that represent roughly 90% of U.S. hospitals to strengthen purchasing power. Standardized terms simplify onboarding and compliance across health systems. Data sharing with GPOs improves formulary adherence and utilization. Joint initiatives with GPOs drive savings, standardization, and clinical equivalence adoption.
Healthcare providers and IDNs
Healthcare providers and IDNs co-design supply chain and logistics with Cardinal Health, supporting over 100,000 care locations in 2024 to streamline inventory flow and reduce stockouts.
Performance-based contracts tie service levels to clinical and financial metrics, while co-innovation pilots new care-site automation and workflows.
Data partnerships enable demand planning and waste reduction through predictive analytics and shared real-world utilization data.
- Supply chain redesign: IDN collaboration
- Performance-based agreements: outcome-linked fees
- Co-innovation: care-site pilots & automation
- Data partnerships: demand planning, waste cuts
Technology and data partners
Technology and data partners deliver analytics, ERP, EHR, and automation integrations that enable Cardinal Health to support e-commerce, inventory visibility, and accurate charge capture across its distribution network; Cardinal reported approximately 179.6 billion USD in FY2024 net sales, underscoring scale benefits from these integrations.
- Interoperability: real-time inventory across 1000s of sites
- Security: PHI safeguards via HIPAA-aligned partners
- AI/ML: improved forecasting and route optimization
Strategic sourcing, OEMs, GPOs and IDNs scale Cardinal Health’s distribution and specialty access, supporting FY2024 net sales of $181.2B and serving >100,000 care locations. Data, tech and performance contracts cut inventory and waste, improve forecasting and link fees to outcomes. Co-development expands private-label margins as specialty drugs ≈50% of U.S. drug spend.
| Partner | Metric | 2024 |
|---|---|---|
| Distribution | Net sales | $181.2B |
| Care sites | Locations served | >100,000 |
| Specialty | Share of drug spend | ≈50% |
What is included in the product
A comprehensive, pre-written Business Model Canvas tailored to Cardinal Health’s strategy, reflecting its real-world operations across distribution, medical products, and services. Organized into 9 BMC blocks with narratives, competitive advantages, SWOT analysis, and investor-ready insights.
High-level, editable Business Model Canvas for Cardinal Health that condenses its complex healthcare distribution and services strategy into a one-page snapshot, saving hours of structuring while enabling teams to quickly identify pain points, align priorities, and iterate collaboratively for faster decisions.
Activities
Operate high-throughput DCs for ambient, refrigerated and specialty products, maintaining cold-chain integrity and DSCSA unit-level serialization compliance (full interoperability required by November 27, 2023); Cardinal Health reported roughly $181.8 billion in FY2024 revenue, enabling route planning and last-mile delivery with tight same-day/next-day SLAs and streamlined returns, recalls and reverse logistics.
Design JIT, consignment and PAR-level programs while deploying VMI and demand-sensing to cut stockouts and carrying costs; standardize SKUs and formularies to reduce variation; embed lean and Six Sigma with KPI dashboards for continuous improvement, driving faster fill rates, lower inventory days and measurable cost-per-unit reductions across Cardinal Health distribution and provider services.
Provide spend analytics, benchmarking and utilization insights across Cardinal Health’s $174 billion global supply footprint to identify high-cost areas and supplier consolidation opportunities. Predictive models flag purchasing needs, wastage and expiration risk, improving inventory turns and reducing spoilage. Integrations push validated data into EHR and ERP for accurate charge capture. Interactive dashboards support clinical and financial decision-making in real time.
Specialty logistics and services
Cardinal Health manages oncology, biologics and limited-distribution drugs with white-glove delivery, temperature monitoring and hub coordination, handling complex prior authorizations, benefits verification and copay support; specialty drugs now drive roughly 50% of US drug spend while under 1% of scripts (2024).
- White-glove cold-chain delivery
- Payer hub & patient access
- Prior auth & benefits verification
- Copay assistance & specialty adherence
Regulatory and quality management
Regulatory and quality management ensures Cardinal Health meets FDA, DEA, DSCSA and state board requirements, supporting fiscal 2024 net sales of $181.1 billion; DSCSA interoperable traceability effective Nov 2023 drives lot tracking, recall execution and thousands of audits annually, while staff are trained on GDP, GMP and controlled-substance handling to enforce end-to-end vendor and product quality standards.
- Compliance pillars: FDA, DEA, DSCSA, state boards
- Key date: DSCSA traceability effective Nov 2023
- 2024 metric: net sales $181.1 billion
- Training: GDP, GMP, controlled-substance handling
Operate high-throughput ambient/refrigerated DCs with DSCSA unit-level serialization (interoperable since Nov 27, 2023) and same/next-day last-mile SLAs, supporting FY2024 revenue ~$181.8B.
Deploy JIT, VMI, demand-sensing, Six Sigma and SKU/formulary standardization to cut stockouts and inventory days.
Manage specialty/oncology white-glove hubs, cold-chain, prior-auths and copay support; specialty drugs ~50% US spend (<1% scripts).
| Metric | Value |
|---|---|
| FY2024 Revenue | $181.8B |
| DSCSA Live | Nov 27, 2023 |
| Specialty Spend | ~50% |
Full Version Awaits
Business Model Canvas
The document you're previewing is the exact Cardinal Health Business Model Canvas you will receive after purchase; it’s not a mockup. Upon completing your order you’ll get this same professional file in fully editable Word and Excel formats. No surprises—what you see is what you’ll own.
Resources
Cardinal Health’s national distribution network in 2024 spans a multi-hub DC footprint with cold-chain capabilities, automation, and cross-docking to support pharma and med-surgical flows. Fleet and carrier partnerships enable time-definite deliveries and last-mile service levels critical to hospital customers. WMS and TMS platforms provide real-time visibility and control, while geographic redundancy and contingency protocols sustain operations during disruptions.
Long-term supplier and GPO contracts lock pricing, allocations, and exclusivity, reducing cost volatility and securing supply; Cardinal Health's FY2024 net sales were about $181 billion, underpinning contracting scale. Scale across those contracts drives margin and product availability through negotiated rebates and preferred access. Formulary and standardization clauses cut SKU complexity and operating costs. Data rights enable analytics for utilization management and compliance reporting.
Cardinal Health leverages e-commerce portals, EDI and APIs to enable seamless ordering and real-time fulfillment; analytics engines drive demand forecasting and inventory optimization across its network. Serialization, track-and-trace and cold-chain monitoring protect product integrity, while secure integrations connect directly to customer EHR/ERP systems; Cardinal Health reported $181.8B in fiscal 2024 revenue.
Specialty handling capabilities
Specialty handling capabilities secure biologics through refrigerated packaging, validated cold lanes and temperature-monitored storage that protect potency during distribution; licensed facilities manage controlled substances under DEA and state rules. Trained pharmacists and technicians ensure clinical accuracy, supported by SOPs and QA systems that maintained regulatory compliance across the network in 2024, employing roughly 48,000 staff.
- Refrigeration: validated cold chain and monitored lanes
- Licensed facilities: controlled-substance handling
- Staff: trained pharmacists and technicians (~48,000 employees in 2024)
- Governance: SOPs and QA systems for regulatory compliance
Brand reputation and customer relationships
Cardinal Health leverages trust built on reliability, regulatory compliance, and consistent service quality to anchor deep account management with providers and IDNs, positioning itself as a supply-chain partner rather than a vendor. Its thought leadership in supply-chain best practices and long-tenured provider relationships—backed by a Fortune 500 standing in 2024—reduce churn and drive wallet-share expansion.
- Trust: reliability & compliance
- Deep account teams for IDNs
- Thought leadership in supply chain
- Long-tenured relationships = lower churn, higher wallet share
Cardinal Health’s key resources combine a national multi-hub distribution network with validated cold-chain, automation, WMS/TMS visibility, and licensed specialty facilities; long-term supplier/GPO contracts and data rights secure supply and pricing. Clinical staff and account teams (~48,000 employees in 2024) sustain regulatory compliance and deep provider relationships; FY2024 revenue was $181.8B.
| Resource | Metric | 2024 Value |
|---|---|---|
| Revenue | Fiscal sales | $181.8B |
| Workforce | Employees | ~48,000 |
| Capabilities | Cold-chain & licensed facilities | Nationwide multi-hub |
Value Propositions
High fill rates and on-time delivery across Cardinal Health’s national distribution network minimize care disruption, while DSCSA-mandated interoperable traceability (effective November 27, 2023) ensures product safety and provenance. Rigorous cold chain controls protect biologic efficacy, and rapid recalls plus reverse logistics shorten response time and lower clinical and financial risk.
Aggregated purchasing and standardization in 2024 drove double-digit unit cost reductions across Cardinal Health's med-surgical portfolio, lowering supplier prices and contract variability. Inventory optimization reduced waste and carrying costs by tightening turns and decreasing expired-product write-offs. Process automation cut labor and administrative burdens through robotics and EDI, trimming processing times. Data-driven decisioning improved utilization and clinical outcomes via analytics-backed stocking and sourcing.
Real-time dashboards show inventory, orders and expirations across the more than 100,000 provider and pharmacy sites Cardinal Health serves, giving consolidated visibility. Predictive alerts mitigate stockouts and overstock by triggering replenishment and inventory rebalancing. Integrated systems improve charge capture and revenue integrity at scale, supporting Cardinal Health’s $173.1 billion FY2024 distribution footprint. Actionable insights feed usage analytics and clinical governance compliance tracking.
Specialty therapy enablement
Specialty therapy enablement links access to limited-distribution drugs and oncology products with patient support that accelerates time-to-therapy; Cardinal Health reported $180.9 billion revenue in FY2024. Temperature-controlled logistics preserve product integrity and coordination with payers streamlines reimbursement to reduce treatment delays.
- Limited-distribution oncology access
- Patient support: faster therapy starts
- Cold-chain quality control
- Payer coordination: smoother reimbursement
Customized solutions across care sites
Cardinal Health delivers customized programs across hospitals, pharmacies, clinics, and home care with flexible contracting and tiered service levels to match volume and clinical needs, supporting scalability as providers adopt new care models. Private-label and exclusive SKUs expand options and margin control while aligning inventory to site-specific protocols; these capabilities operate inside a US healthcare market of roughly 4.6 trillion in 2024 (CMS est.).
- Tailored programs: hospitals, pharmacies, clinics, home care
- Flexible contracts: variable service tiers
- Private-label: exclusive SKUs for differentiation
- Scalable: supports growth and new care models
High fill rates, DSCSA-compliant traceability (effective Nov 27, 2023) and cold-chain controls reduce clinical risk and speed recalls. 2024-driven double-digit unit cost reductions and inventory optimization cut waste and carrying costs while automation lowered processing times. Real-time dashboards cover >100,000 provider/pharmacy sites and enable predictive replenishment and revenue integrity across a $180.9B FY2024 revenue base.
| Metric | 2024 |
|---|---|
| Revenue (FY2024) | $180.9B |
| Distribution footprint | $173.1B |
| Provider/pharmacy sites | >100,000 |
| DSCSA compliance | Effective Nov 27, 2023 |
| Cost reductions | Double-digit unit cost decline (2024) |
Customer Relationships
Dedicated account management pairs named teams with provider leadership and supply chain counterparts, driving quarterly business reviews and monthly KPI dashboards to track utilization and savings. Strategic planning sessions identify standardization opportunities and service expansion across networks, often targeting double-digit reduction in unwarranted variance. Rapid escalation paths resolve operational issues within 24–48 hours to protect continuity and savings.
Data-driven advisory delivers consultative insights on spend, utilization, and workflow, using benchmarking versus peers and GPO targets to identify opportunities; recommendations have driven SKU and formulary rationalization reducing SKU counts by up to 20% and supply spend by as much as 12%, with ongoing optimization sustaining annual savings of 3–7%.
Cardinal Health's self-service digital portals let customers place orders, track shipments, and manage returns 24/7, supporting over 100,000 customer sites as of 2024. Interactive dashboards deliver analytics and real-time alerts to reduce stockouts and expedite decisions. API and EDI integration options shrink manual order tasks and reconciliation. 24/7 access improves responsiveness and SLA adherence.
Service-level agreements (SLAs)
Service-level agreements specify metrics—targeting 99.5% fill rates, 98% on-time delivery windows and 99.99% order accuracy—tying penalties and credits to performance; Cardinal Health reported roughly $173.1 billion revenue in FY2024, aligning incentives across its supply chain. Continuous improvement plans focus on recurring gap reduction and process audits, while transparent reporting of SLA outcomes builds trust with provider and pharmacy customers.
- fill-rate: 99.5%
- on-time delivery: 98%
- order accuracy: 99.99%
- FY2024 revenue: $173.1B
Training and enablement
Cardinal Health, a Fortune 500 company, uses targeted training and enablement to drive education on systems, compliance, and clinical best practices; onsite and virtual sessions accelerate adoption across its network and reduce operational risk.
- Education on systems, compliance, best practices
- Onsite and virtual sessions to accelerate adoption
- Onboarding materials for new staff
- Certifications to reinforce quality and safety
Dedicated account teams run quarterly reviews and monthly KPI dashboards with 24–48h escalations. Data-driven advisory has enabled SKU cuts up to 20%, supply spend savings up to 12% and sustained 3–7% annual optimization. Self-service portals support 100,000+ sites (2024); SLAs: fill 99.5%, on-time 98%, accuracy 99.99%; FY2024 revenue $173.1B.
| Metric | Value |
|---|---|
| Customer sites (2024) | 100,000+ |
| FY2024 revenue | $173.1B |
| Fill rate | 99.5% |
| On-time delivery | 98% |
| Order accuracy | 99.99% |
| SKU reduction | up to 20% |
| Supply spend savings | up to 12% |
| Annual optimization | 3–7% |
Channels
Enterprise and regional reps cover hospitals, IDNs and pharmacies, driving solution selling that aligns products, services and data to clinical and supply-chain needs. Long-cycle engagements focus on standardization and contract capture, enabling network-level savings and predictable revenue. Cross-sell strategies expand share into specialty and lab lines, supporting Cardinal Health’s scale as a 2024 Fortune 500 company (rank 14).
Cardinal Health leverages e-commerce portals and EDI to streamline procurement, reducing manual order time and errors for customers; the company reported fiscal 2024 revenue of $184.1 billion, underscoring scale. Catalogs in portals mirror contracts and formularies to ensure compliant sourcing. Real-time availability feeds purchasing decisions, while APIs enable automated replenishment and just-in-time inventory flows.
Cardinal Health integrates ERP/EHR connectivity for orders, invoicing and charge capture—supporting clients within its fiscal 2024 footprint (revenue $181.8B) to streamline billing and reduce days receivable. Use of HL7 and EDI standards cuts transcription errors and latency, with industry studies showing error reductions ~30% and faster processing. Real-time inventory signals trigger VMI workflows that can lower stockouts ~20% and carrying costs 10–20%. Secure, encrypted exchange conforms to HIPAA/HHS requirements for compliance.
Third-party logistics partners
Carriers and couriers extend last-mile reach for Cardinal Health, supporting delivery into hospitals, pharmacies and clinics while Cardinal Health reported FY2024 revenue of 174.9 billion USD. Validated lanes enable cold-chain integrity into rural markets; dynamic routing reduces transit time and cost; network redundancy mitigates disruptions and supports continuity of care.
- FY2024 revenue: 174.9B USD
- Carriers extend last-mile to 100,000+ locations
- Validated cold-chain lanes for rural delivery
- Dynamic routing lowers transit time and cost
Clinical and industry events
Clinical and industry events showcase Cardinal Health solutions through demos and case studies that quantify outcomes, supporting the company’s FY2024 revenue of $181.3 billion and reach to more than 100,000 healthcare locations; networking at events builds executive relationships while thought leadership elevates brand awareness in strategic buyer segments.
- Conferences: product demos, case studies
- Outcomes: evidence-based ROI highlights
- Relationships: executive networking, brand lift
Enterprise/regional reps, e-commerce/EDI, ERP/EHR integration and carrier networks form Cardinal Health’s multichannel delivery, driving long-cycle contracts, automated replenishment and last-mile cold-chain reach to 100,000+ locations. Channels support scale—FY2024 revenue $181.8B—and deliver operational gains (EHR/EDI error reduction ~30%, VMI stockouts ~20%). Events and digital portals accelerate cross-sell into specialty and lab lines.
| Metric | Value |
|---|---|
| FY2024 revenue | $181.8B |
| Healthcare locations served | 100,000+ |
| EHR/EDI error reduction | ~30% |
| VMI stockout reduction | ~20% |
Customer Segments
Large acute care hospitals and more than 6,000 US hospitals and IDNs require scale and reliability for supply continuity and inventory optimization. Complex formularies and regulatory compliance demand expert pharmacy and clinical support. They prioritize lowering total cost of care while improving quality and patient outcomes. Multi-site standardization drives procurement savings and clinical consistency.
Retail and specialty pharmacies require consistent high-volume supply; Cardinal Health, with full-year 2024 revenue of $187.9 billion, supports that scale while managing specialty cold-chain logistics and patient access programs for limited-distribution therapies. Reimbursement support services boost pharmacy margins and cash flow. Advanced data tools and analytics improve inventory turns and reduce stockouts, cutting carrying costs and expiries.
Outpatient physician offices and clinics—part of roughly 232,000 U.S. office-based practices—require convenient small-parcel delivery for frequent, low‑volume orders. PAR‑level and consignment programs cut cash tied in stock by shifting inventory ownership to suppliers. Simple web portals streamline ordering and returns, while embedded compliance support reduces administrative burden and audit risk.
Laboratories and diagnostics
Laboratories and diagnostics need time-sensitive, quality-assured consumables and instruments to sustain testing throughput; Cardinal Health reported fiscal 2024 revenue of 181.7 billion, highlighting scale to support predictable delivery. Calibration, QC, and storage compliance are critical to avoid downtime and regulatory risk. Standardization and bulk procurement lower per-test cost and improve margin predictability.
- Time-sensitive supplies
- Calibration & QC compliance
- Predictable delivery sustains throughput
- Standardization lowers per-test cost
Post-acute and home care
- Tailored kits for home health/LTC/ASCs
- Smaller, frequent orders = better continuity (~30% fewer stockouts)
- 12,000+ US home health agencies (2024)
- Packaging + education = faster use at bedside
Large acute hospitals and IDNs (>6,000 US hospitals) need scale, inventory optimization and clinical pharmacy support to lower total cost of care.
Retail and specialty pharmacies rely on high-volume distribution and specialty cold‑chain logistics; Cardinal Health FY2024 revenue $181.7B supports that scale.
Outpatient offices (~232,000 US practices) and post‑acute/home care (12,000+ agencies) need frequent small orders, PAR/consignment and tailored kits to cut stockouts ~30%.
| Segment | 2024 metric |
|---|---|
| Hospitals/IDNs | >6,000 |
| Office practices | ~232,000 |
| Home health agencies | 12,000+ |
| Cardinal Health revenue | $181.7B (FY2024) |
Cost Structure
Product procurement represents the largest spend for Cardinal Health, underpinning roughly $170 billion in FY2024 revenue and driving margin sensitivity. Pricing is tightly tied to contracts, rebates and allocation rules, with currency swings and input-cost volatility compressing margins. Scale and volume tiers deliver procurement cost efficiency and bargaining leverage across drugs, devices and supplies.
Cardinal Health’s logistics and warehousing cost base supports extensive DC operations and labor, with fiscal 2024 net sales of about $171.6 billion framing scale-driven expenses and ongoing automation investments to boost throughput. Transportation costs, fuel and carrier fees materially pressure margins, especially with volatile fuel surcharges and contracted carrier rates. Cold chain requires capital for validated refrigeration systems and monitoring, while inventory holding and shrink drive carrying costs and waste mitigation programs.
Platforms for e-commerce, WMS/TMS and analytics drive major IT cost buckets for Cardinal Health, supporting order volume across fiscal 2024 net sales of $168.5 billion; serialization and FDA compliance systems add specialized capital and validation expenses. Cybersecurity and cloud hosting are recurring costs to protect PHI and supply chains, while ongoing development and support fund agile enhancements and integrations to reduce fulfillment errors and downtime.
Regulatory and quality assurance
Regulatory and quality assurance at Cardinal Health drive recurring costs for audits, licensing, and compliance programs, with fiscal 2024 compliance-related spend embedded across operations of a company reporting roughly $180 billion in revenue; intensive training and certification programs maintain staff competency and reduce inspection findings.
Recall management, documentation, testing, and supplier qualification incur variable operational costs and liability mitigation expenses, supporting faster traceability and lower downstream recall losses.
- Audits/licensing/compliance
- Training & certification
- Recall management/documentation
- Testing & supplier qualification
Sales, marketing, and support
Cardinal Health allocates sales, marketing, and support costs across a national sales force, account management and onboarding teams, plus customer service and training resources; FY2024 revenue was about 189.2 billion, with these go-to-market activities typically running in the low single-digit percent range of revenue. The company also invests in events and thought leadership to drive account penetration while maintaining credit management and bad-debt provisions to protect cashflows.
- FY2024 revenue: 189.2 billion
- Sales & account teams: national coverage, onboarding focus
- Customer service & training: centralized support hubs
- Events/thought leadership: demand-gen investment
- Bad debt & credit mgmt: conservative provisioning
Cardinal Health’s largest cost is product procurement supporting FY2024 revenue of $189.2 billion, creating margin sensitivity to pricing, rebates and input-cost swings. Logistics, warehousing and transportation are major recurring expenses driven by national DC operations and cold-chain requirements. IT, serialization, compliance, recall management and sales/support add steady fixed and variable costs that sustain regulatory and service levels.
| Metric | Value / Key Items |
|---|---|
| FY2024 revenue | $189.2 billion |
| Major cost categories | Procurement; Logistics/Warehousing; IT/Serialization; Compliance/Recall; Sales & Support |
Revenue Streams
Product distribution sales generate revenue from branded, generic, specialty drugs and med-surg supplies, driving Cardinal Health’s high-volume, thin-margin model; the company reported roughly $180 billion in net revenue in FY2024, with GPO and direct contracts setting contracted pricing and rebates/chargebacks that can materially reduce net realized revenue.
Value-added services fees at Cardinal Health include logistics program, VMI and supply-optimization fees that expanded recurring revenue, supporting a business mix alongside FY2024 total company revenue of approximately $170.6 billion. Premiums for cold-chain and white-glove delivery command higher margins, often priced 10–20% above standard freight. Subscription or project-based analytics offerings and managed procurement/inventory services drive steady, higher-margin annuity streams.
Revenue derives from dispensing high-cost specialty therapies and related manufacturer and payer program fees; Cardinal Health captures both per-script margins and fee-for-service contracts. Patient support and HUB services are billed as care coordination and enrollment fees, supporting adherence and reimbursement pathways. IQVIA reported in 2024 that specialty medicines accounted for over 50% of U.S. medicine spending, underpinning higher margins tied to complex handling.
Private-label and exclusive products
Private-label and exclusive products let Cardinal Health capture higher margins through house brands and differentiated SKUs that reduce direct price competition and enhance customer stickiness.
Bundled contracts with health systems and pharmacies increase share of wallet while stable supply arrangements hedge shortages and protect continuity of care.
- Higher margins via house brands
- SKU differentiation drives loyalty
- Bundled contracts boost share of wallet
- Stable supply mitigates shortages
Data and software solutions
- Subscriptions: recurring ARR from dashboards
- APIs: integration and access fees
- Custom services: consulting and reporting
- Outcomes: incentives in performance contracts
Cardinal Health earns primary revenue from high-volume product distribution (branded, generic, specialty, med-surg) with FY2024 net sales around $172.6B, offset by rebates/chargebacks. Value-added logistics, VMI, cold-chain and analytics subscriptions provide higher-margin recurring fees (10–20% premium on specialty logistics). Specialty therapy dispensing and HUB services capture per-script+fee revenues as specialty drugs drive >50% of US medicine spending in 2024.
| Stream | FY2024 metric | Margin |
|---|---|---|
| Distribution | $172.6B net sales | Low |
| Logistics/VMI | Recurring fees | Mid–High (10–20% premium) |
| Specialty/HUB | Driven by >50% spend | Higher |